Illumina Sequencing and array-based solutions for ...
Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics.…
Company Overview An innovative genomics company - Illumina
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers.…
ILMN Stock Price Illumina Inc. Stock Quote (U.S.: Nasdaq ...
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.…
Illumina Corporate Fact Sheet Key facts about the company
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us ……
Illumina, Inc. - Financial Information
At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with ……
Illumina, Inc. - Investors
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.…
Home In re Illumina, Inc Securities Litigation
The Settlement resolves class action litigation over whether Illumina, and certain Illumina executives, made materially false or misleading statements or omissions to investors concerning, among other things, Illumina’s July 26, 2016 earnings guidance, which projected that the Company would earn revenue of between $625 million and $630 ...…